Stephen K. Brannan, MD

  • 3Articles
  • 32.5KReads1
  • 2005–2025Active
  • 22Collaborators
  • 73Citations2

About

Stephen K. Brannan, MD, affiliated with Medical Affairs at Bristol Myers Squibb in Princeton, New Jersey, has published extensively on schizophrenia, schizoaffective disorders, and major depressive disorder. His work includes studies on the safety, tolerability, and antipsychotic efficacy of treatments such as xanomeline and trospium chloride, as well as investigations into sexual functioning related to duloxetine in depression. His research spans from 2005 to 2025 and has appeared in peer-reviewed journals including Psychiatrist.com.

Publications

JCP
Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From the EMERGENT Trials
Original Research

Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From the EMERGENT Trials

February 26, 2025

In pooled analyses, xanomeline/trospium was generally well tolerated. The most common adverse events were mild or moderate, transient, and consistent with the activity of xanomeline and trospium at muscarinic...
, , , et al
JCP
Antipsychotic Efficacy of KarXT (Xanomeline−Trospium)
Original Research

Antipsychotic Efficacy of KarXT (Xanomeline−Trospium)

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ May 11, 2022

This post hoc analysis of phase 2 data evaluated rates and time course of response with the new combination oral agent KarXT (xanomeline−trospium) in the treatment of schizophrenia.
, , , et al
JCP
Original Research

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

June 15, 2005

, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe